Compounds and methods for the treatment of cystic fibrosis
AssigneeFlatley Discovery Lab, LLC
InventorsMichael P. Zawistoski, Christopher Oalmann, Feng Li, Andrew Kolodziej, Marshall Morningstar
Life of this patent
Estimating the term…
Abstract
The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I, and pharmaceutically acceptable slats thereof, pharmaceutical compositions comprising such compounds and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula Ito a subject in need thereof.
Claims28
A compound of Formula (I)
- or a pharmaceutically acceptable salt thereof, wherein:
- R and R1 are independently selected from hydrogen, optionally substituted alkyl;
- optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted arylalky, optionally substituted heteroaryl or optionally substituted heteroarylalkyl;
- or R and R1, together with the nitrogen atom to which they are attached, form an optionally substituted 3 to 7-membered heterocyclyl;
- R2 is hydrogen, optionally substituted alkyl, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl;
- R3 is hydrogen, optionally substituted alkyl, R7C(O)—, R7SO2— or R7NHC(O)—;
- or R2 and R3, together with the atoms to which they are attached, form an optionally substituted 3 to 7-membered heterocyclyl;
- Each R4 is independently halogen, optionally substituted alkyl, CN, optionally substituted alkoxy, NR12R13, or hydroxy;
- R5 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, or optionally substituted cycloalkyl;
- R6 is OR8, SR8 or NR9R10;
- R7 is optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted aryl, or optionally substituted arylalkyl;
- R8 is hydrogen, optionally substituted alkyl;
- optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted heteroaryl;
- R9 is hydrogen, OR11, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl;
- optionally substituted aryl, optionally substituted heteroaryl, heterocyclyl, SO2—R8, SO2NRaRb or N(Ra)Rb;
- R10 is hydrogen;
- optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl;
- optionally substituted aryl or optionally substituted heteroaryl;
- or R9 and R10, together with the nitrogen atom to which they are attached, form an optionally substituted heterocyclyl;
- Ra and Rb are each independently hydrogen, optionally substituted alkyl;
- optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted heteroaryl;
- R11 is hydrogen or optionally substituted alkyl;
- R12 and R13 are each independently hydrogen, optionally substituted alkyl, R7C(O)—, R7SO2— or R7NHC(O)—;
- or R12 and R13, together with the nitrogen atom to which they are attached, form an optionally substituted heterocyclyl;
- and
- n is 0, 1, 2, 3 or 4.
(canceled)
-8 (canceled)
-13. (canceled)
-18. (canceled)
-29. (canceled)
(canceled)
(anceled)
A compound selected from the compounds set forth in the table below, or a pharmaceutically acceptable salt thereof,
- Compound No.
- Structure
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66.9a 66.9b.1 66.9b.2 66.9b.3
- 67.9a 67.9b
- 68.a 68.b 68.c
- 69.a 69.b
- 70.a 70.b 70.c
- 71.a
- 72.a 72.b 72.c
- 73.a 73.b 73.c
- 74.a
- 75.a
- 76.a 76.b 76.c 76.d
- 77.a 77.b
- 78.a
- 79a 79b 79c
- 80.7a.1 80.7a.2 80.7b.1 80.7b.2
- 81
- 82.6a
- 82.6b
- 83a
- 83b
- 84a
- 84b
- 85a
- 85b
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 100.6b
- 101
- 102
- 103
- 104
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 216.8a
- 216.8b
- 217a
- 217b
- 218a
- 218b
- 219
- 220.7a 220.7c
- 225a 225b
- 226a 226b
- 227
- 228
- 229a 229b
- 230
- 231
- 232a
- 232b
- 233
- 234a 234b
- 235a 235b
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- 248
- 249a
- 249b
- 250.3a
- 250.3b
- 251a
- 251c
- 252
- 253
- 254a
- 254b
- 255a
- 255b
- 256a
- 256b
- 257
- 258
- 259
- 260a
- 260b
- 261
- 265a
- 265b
- 266
- 267
- 268a 268b
- 269a
- 269b
- 270a
- 270b
- 271
- 272
- 273a 273b
- 274.6a
- 274.6b
- 275.7a
- 275.7b
- 280
- 281
- 282
- 284
- 285
- 286a 286b
- 287
- 288a
- 288b
- 289
- 290
- 291
- 292
- 293
- 294
(canceled)
Dependencies are inferred from the claim text.